title: p21(WAF1) is associated with CDK2 and CDK4 protein during HL-60 cell differentiation by TPA treatment.
abstract: TPA-treated HL-60 cells are mainly arrested in G1 by p21(WAF1) accumulation. We investigate the downstream changes following such accumulation. Increased p21(WAF1) is associated with CDK2 and CDK4. pRb is dephosphorylated in the presence of p21-CDK2/4 complexes, and the Rb-E2F1 complex increases after TPA treatment, whereas the Rb-HDAC1 complex decreases slightly. Our results suggest that increased p21(WAF1) is associated with CDK2/4, and that these complexes induce pRb dephosphorylation. In turn, hypophosphorylated pRb are mainly complexed with E2F1, but HDAC1 appears not to be a key component in this process.
authors.affiliation: Department of Microbiology, College of Medicine, Seonam University, Kwangchi-Dong 720, Namwon, Chunpook 590-711, Korea.
authors.forename: J W
authors.initials: JW
authors.lastname: Cho
authors.forename: Y W
authors.initials: YW
authors.lastname: Jeong
authors.forename: K S
authors.initials: KS
authors.lastname: Kim
authors.forename: J Y
authors.initials: JY
authors.lastname: Oh
authors.forename: J C
authors.initials: JC
authors.lastname: Park
authors.forename: J C
authors.initials: JC
authors.lastname: Lee
authors.forename: W K
authors.initials: WK
authors.lastname: Baek
authors.forename: S I
authors.initials: SI
authors.lastname: Suh
authors.forename: M H
authors.initials: MH
authors.lastname: Suh
mesh_terms: D042846:CDC2-CDC28 Kinases; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology*; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology*; D051357:Cyclin-Dependent Kinase 2; D051358:Cyclin-Dependent Kinase 4; D050759:Cyclin-Dependent Kinase Inhibitor p21; D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D016213:Cyclins / Q000378:metabolism*; D053938:DNA Fragmentation; D004791:Enzyme Inhibitors / Q000378:metabolism; D016193:G1 Phase; D018922:HL-60 Cells; D006801:Humans; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D011518:Proto-Oncogene Proteins; D016160:Retinoblastoma Protein / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
chemical_list: C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D004791:Enzyme Inhibitors; D011518:Proto-Oncogene Proteins; D016160:Retinoblastoma Protein; D017346:Protein Serine-Threonine Kinases; D042846:CDC2-CDC28 Kinases; C495894:CDK2 protein, human; C495900:CDK4 protein, human; D051357:Cyclin-Dependent Kinase 2; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases; D013755:Tetradecanoylphorbol Acetate